Zinc paste, Calamine and Clioquinol bandage BP 7.5cm x 6m
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 26 studies.
Reviews & meta-analyses: 5 · 1993–2025
Showing all 26 studies, sorted by most relevant.
Leilei Chen, Qing-qing Shen, Yingjuan Liu, et al.
Signal Transduction and Targeted Therapy, 2025
- Ferroptosis
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
As essential micronutrients, metal ions such as iron, manganese, copper, and zinc, are required for a wide range of physiological processes in the brain. However, an imbalance in metal ions, whether excessive or insufficient, is detrimental and can contribute to neuronal death through oxidative stress, ferroptosis, cuproptosis, cell senescence, or neuroinflammation. These processes have been found to be involved in the pathological mechanisms of neurodegenerative diseases. In this review, the research history and milestone events of studying metal ions, including iron, manganese, copper, and zinc in neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD), will be introduced. Then, the upstream regulators, downstream effector, and crosstalk of mental ions under both physiologic and pathologic conditions will be summarized. Finally, the therapeutic effects of metal ion chelators, such as clioquinol, quercetin, curcumin, coumarin, and their derivatives for the treatment of neurodegenerative diseases will be discussed. Additionally, the promising results and limitations observed in clinical trials of these metal ion chelators will also be addressed. This review will not only provide a comprehensive understanding of the role of metal ions in disease development but also offer perspectives on their modulation for the prevention or treatment of neurodegenerative diseases.
Abstract licence: CC BY
L. Costello, R. Franklin
Archives of biochemistry and biophysics, 2016
- Aconitate Hydratase
- Biological Transport
- Citrates
Mrinal Gupta, V. Mahajan, K. Mehta, et al.
Dermatology Research and Practice, 2014
Zinc, both in elemental or in its salt forms, has been used as a therapeutic modality for centuries. Topical preparations like zinc oxide, calamine, or zinc pyrithione have been in use as photoprotecting, soothing agents or as active ingredient of antidandruff shampoos. Its use has expanded manifold over the years for a number of dermatological conditions including infections (leishmaniasis, warts), inflammatory dermatoses (acne vulgaris, rosacea), pigmentary disorders (melasma), and neoplasias (basal cell carcinoma). Although the role of oral zinc is well-established in human zinc deficiency syndromes including acrodermatitis enteropathica, it is only in recent years that importance of zinc as a micronutrient essential for infant growth and development has been recognized. The paper reviews various dermatological uses of zinc.
Abstract licence: CC BY
S. Bareggi, U. Cornelli
CNS Neuroscience & Therapeutics, 2012
- Clinical Trials as Topic
- Disease Models, Animal
- Clioquinol
M. Boni, N. Mondillo
Ore Geology Reviews, 2015
Xiaodong Zhang, Long Chen, Yangbo Sun, et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018
- Algorithms
- Calibration
- Drug Combinations
Andrew Adamatzky, Nic Roberts, Raphael Fortulan, et al.
Scientific Reports, 2024
The colloid cellular automata do not imitate the physical structure of colloids but are governed by logical functions derived from them. We analyze the space-time complexity of Boolean circuits derived from the electrical responses of colloids-specifically ZnO (zinc oxide, an inorganic compound also known as calamine or zinc white, which naturally occurs as the mineral zincite), proteinoids (microspheres and crystals of thermal abiotic proteins), and their combinations in response to electrical stimulation. To extract Boolean circuits from colloids, we send all possible configurations of two-, four-, and eight-bit binary strings, encoded as electrical potential values, to the colloids, record their responses, and infer the Boolean functions they implement. We map the discovered functions onto the cell-state transition rules of cellular automata-arrays of binary state machines that update their states synchronously according to the same rule-creating the colloid cellular automata. We then analyze the phenomenology of the space-time configurations of the automata and evaluate their complexity using measures such as compressibility, Shannon entropy, Simpson diversity, and expressivity. A hierarchy of phenomenological and measurable space-time complexity is constructed.
Abstract licence: CC BY
Oxford English Dictionary, 2023
Luan Van Pham, Thanh-Hai Pham, N. Q. T. Do, et al.
Inżynieria Mineralna, 2025
Cho-Dien zinc oxide ore is characterized by strong weathering. The ore has a content of 6-10% zinc content. Zinc occurs mainly in hemimorphite (calamine), smithsonite and chalcophanite. The rocks are mainly goethite, clay and quartz. However, no feasibility study has been conducted to treat this ore in practical production. This paper presents the effects of different types of flotation reagents (collectors, depressants, dispersers, etc.) on the beneficiation process of zinc oxide ore. From there, the suitable flotation reagents dosages and regimes were given. The research result shows the concentrate has a content of 20-25 % Zn at a recovery ratio of 55-60%. These preliminary results suggest that developing a technically and economically feasible beneficiation technology for Cho-Dien zinc oxide ore is possible.
Abstract licence: CC BY
Masato Katsuyama
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2024
- Clioquinol
- Optic Nerve Diseases
- Copper Transport Proteins
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.